Clonegene develops antibodies and enzymes of utility in research and clinical applications. Many of these reagents are available to be licensed or distributed. We are currently focusing on novel antibodies useful in the therapy of Small Cell Lung Cancer.
Looking for a particular CLONEGENE LLC employee's phone or email?
The CLONEGENE LLC annual revenue was $4 million in 2026.
CLONEGENE LLC is based in Hartford, Connecticut.
The NAICS codes for CLONEGENE LLC are [541714, 54, 5417, 541, 54171].
The SIC codes for CLONEGENE LLC are [873, 87].